25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

NRC (National Research Corp) Stock Analysis
Buy, Hold or Sell?

Let's analyze National Research Corp together

I guess you are interested in National Research Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – National Research Corp’s Financial Insights
  • 📈 Technical Analysis (TA) – National Research Corp’s Price Targets

I'm going to help you getting a better view of National Research Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about National Research Corp

I send you an email if I find something interesting about National Research Corp.

1. Quick Overview

1.1. Quick analysis of National Research Corp (30 sec.)










1.2. What can you expect buying and holding a share of National Research Corp? (30 sec.)

How much money do you get?

How much money do you get?
$0.48
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
$1.29
Expected worth in 1 year
$1.04
How sure are you?
77.5%

+ What do you gain per year?

Total Gains per Share
$0.23
Return On Investment
1.4%

For what price can you sell your share?

Current Price per Share
$16.54
Expected price per share
$13.38 - $18.05
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of National Research Corp (5 min.)




Live pricePrice per Share (EOD)
$16.54
Intrinsic Value Per Share
$3.64 - $11.82
Total Value Per Share
$4.94 - $13.11

2.2. Growth of National Research Corp (5 min.)




Is National Research Corp growing?

Current yearPrevious yearGrowGrow %
How rich?$29.6m$55.3m-$21.4m-63.2%

How much money is National Research Corp making?

Current yearPrevious yearGrowGrow %
Making money$6m$7.5m-$1.5m-25.4%
Net Profit Margin17.1%20.5%--

How much money comes from the company's main activities?

2.3. Financial Health of National Research Corp (5 min.)




2.4. Comparing to competitors in the Health Information Services industry (5 min.)




  Industry Rankings (Health Information Services)  


Richest
#52 / 98

Most Revenue
#41 / 98

Most Profit
#17 / 98
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of National Research Corp?

Welcome investor! National Research Corp's management wants to use your money to grow the business. In return you get a share of National Research Corp.

First you should know what it really means to hold a share of National Research Corp. And how you can make/lose money.

Speculation

The Price per Share of National Research Corp is $16.54. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of National Research Corp.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in National Research Corp, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.29. Based on the TTM, the Book Value Change Per Share is $-0.06 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.37 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.12 per quarter.
Based on historical numbers we can estimate the returns while holding a share of National Research Corp.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.251.5%0.261.6%0.311.9%0.291.8%0.311.9%0.342.1%
Usd Book Value Change Per Share-0.05-0.3%-0.06-0.4%-0.37-2.2%-0.16-1.0%-0.010.0%-0.06-0.3%
Usd Dividend Per Share0.120.7%0.120.7%0.372.2%0.231.4%0.241.4%0.221.3%
Usd Total Gains Per Share0.070.4%0.060.3%0.000.0%0.070.4%0.231.4%0.171.0%
Usd Price Per Share12.80-19.06-41.76-33.52-38.42-35.14-
Price to Earnings Ratio12.70-18.62-34.12-28.60-30.43-24.39-
Price-to-Total Gains Ratio174.74-3,374.42-6.58-1,150.84-299.13-161.82-
Price to Book Ratio9.91-13.10-19.57-15.55-16.42-19.03-
Price-to-Total Gains Ratio174.74-3,374.42-6.58-1,150.84-299.13-161.82-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share16.54
Number of shares60
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.120.24
Usd Book Value Change Per Share-0.06-0.01
Usd Total Gains Per Share0.060.23
Gains per Quarter (60 shares)3.4713.64
Gains per Year (60 shares)13.8854.56
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
129-15456-245
258-3018113-4100
387-4532169-6155
4116-6046226-8210
5144-7560282-9265
6173-9074339-11320
7202-10588395-13375
8231-120102452-15430
9260-135116508-17485
10289-150130565-19540

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%39.01.00.097.5%108.02.00.098.2%
Book Value Change Per Share1.03.00.025.0%5.07.00.041.7%12.08.00.060.0%28.012.00.070.0%88.021.01.080.0%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%78.00.032.070.9%
Total Gains per Share3.01.00.075.0%8.04.00.066.7%15.05.00.075.0%31.09.00.077.5%95.014.01.086.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of National Research Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.047-0.063+32%-0.369+680%-0.160+238%-0.008-83%-0.057+21%
Book Value Per Share--1.2921.442-10%2.256-43%2.181-41%2.414-46%2.446-47%
Current Ratio--0.5400.481+12%0.726-26%0.824-34%1.146-53%1.187-55%
Debt To Asset Ratio--0.7800.736+6%0.558+40%0.588+33%0.557+40%0.523+49%
Debt To Equity Ratio--3.5562.890+23%1.392+155%1.726+106%1.460+144%1.471+142%
Dividend Per Share--0.1210.120+0%0.369-67%0.233-48%0.235-49%0.223-46%
Enterprise Value--191066200.000356437597.500-46%962622655.000-80%757325630.833-75%910701979.500-79%845886539.750-77%
Eps--0.2520.258-2%0.310-19%0.290-13%0.314-20%0.344-27%
Ev To Ebitda Ratio--4.7008.719-46%20.954-78%16.412-71%18.473-75%18.651-75%
Ev To Sales Ratio--1.4242.513-43%6.531-78%5.140-72%6.316-77%6.404-78%
Free Cash Flow Per Share--0.1590.159+0%0.263-39%0.225-29%0.288-45%0.281-43%
Free Cash Flow To Equity Per Share---0.0750.059-228%-0.224+198%-0.133+76%-0.003-96%-0.025-67%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--11.816----------
Intrinsic Value_10Y_min--3.644----------
Intrinsic Value_1Y_max--1.134----------
Intrinsic Value_1Y_min--0.814----------
Intrinsic Value_3Y_max--3.446----------
Intrinsic Value_3Y_min--2.072----------
Intrinsic Value_5Y_max--5.804----------
Intrinsic Value_5Y_min--2.909----------
Market Cap376870516.000+22%294067200.000449475847.500-35%1022850905.000-71%820312714.167-64%961588479.500-69%887579039.750-67%
Net Profit Margin--0.1720.171+1%0.205-16%0.193-11%0.216-20%0.219-21%
Operating Margin--0.2570.248+3%0.273-6%0.272-5%0.294-13%0.296-13%
Operating Ratio--0.7440.752-1%0.731+2%0.730+2%0.708+5%0.705+6%
Pb Ratio12.806+23%9.91113.104-24%19.573-49%15.551-36%16.421-40%19.026-48%
Pe Ratio16.416+23%12.70418.623-32%34.117-63%28.598-56%30.428-58%24.392-48%
Price Per Share16.540+23%12.80019.063-33%41.763-69%33.516-62%38.422-67%35.138-64%
Price To Free Cash Flow Ratio25.956+23%20.08745.282-56%42.917-53%43.228-54%38.913-48%35.952-44%
Price To Total Gains Ratio225.803+23%174.7453374.424-95%6.578+2556%1150.835-85%299.133-42%161.821+8%
Quick Ratio--0.3660.344+6%0.634-42%0.759-52%1.050-65%1.091-66%
Return On Assets--0.0430.047-9%0.061-30%0.055-22%0.058-26%0.057-25%
Return On Equity--0.1950.181+8%0.146+34%0.145+35%0.139+40%0.149+31%
Total Gains Per Share--0.0730.058+27%0.000+101%0.073+0%0.227-68%0.166-56%
Usd Book Value--29672000.00033944250.000-13%55380500.000-46%53365583.333-44%60328550.000-51%61212425.000-52%
Usd Book Value Change Per Share---0.047-0.063+32%-0.369+680%-0.160+238%-0.008-83%-0.057+21%
Usd Book Value Per Share--1.2921.442-10%2.256-43%2.181-41%2.414-46%2.446-47%
Usd Dividend Per Share--0.1210.120+0%0.369-67%0.233-48%0.235-49%0.223-46%
Usd Enterprise Value--191066200.000356437597.500-46%962622655.000-80%757325630.833-75%910701979.500-79%845886539.750-77%
Usd Eps--0.2520.258-2%0.310-19%0.290-13%0.314-20%0.344-27%
Usd Free Cash Flow--3660000.0003734500.000-2%6419750.000-43%5487750.000-33%7207500.000-49%7087250.000-48%
Usd Free Cash Flow Per Share--0.1590.159+0%0.263-39%0.225-29%0.288-45%0.281-43%
Usd Free Cash Flow To Equity Per Share---0.0750.059-228%-0.224+198%-0.133+76%-0.003-96%-0.025-67%
Usd Market Cap376870516.000+22%294067200.000449475847.500-35%1022850905.000-71%820312714.167-64%961588479.500-69%887579039.750-67%
Usd Price Per Share16.540+23%12.80019.063-33%41.763-69%33.516-62%38.422-67%35.138-64%
Usd Profit--5787000.0006052500.000-4%7591500.000-24%7066416.667-18%7813200.000-26%7183850.000-19%
Usd Revenue--33551000.00035324250.000-5%36855000.000-9%36526416.667-8%36206450.000-7%32716825.000+3%
Usd Total Gains Per Share--0.0730.058+27%0.000+101%0.073+0%0.227-68%0.166-56%
 EOD+4 -4MRQTTM+18 -21YOY+12 -273Y+11 -285Y+5 -3410Y+9 -30

3.3 Fundamental Score

Let's check the fundamental score of National Research Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1516.416
Price to Book Ratio (EOD)Between0-112.806
Net Profit Margin (MRQ)Greater than00.172
Operating Margin (MRQ)Greater than00.257
Quick Ratio (MRQ)Greater than10.366
Current Ratio (MRQ)Greater than10.540
Debt to Asset Ratio (MRQ)Less than10.780
Debt to Equity Ratio (MRQ)Less than13.556
Return on Equity (MRQ)Greater than0.150.195
Return on Assets (MRQ)Greater than0.050.043
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of National Research Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.599
Ma 20Greater thanMa 5016.209
Ma 50Greater thanMa 10014.204
Ma 100Greater thanMa 20014.210
OpenGreater thanClose16.573
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About National Research Corp

National Research Corporation provides analytics and insights that facilitate measurement and improvement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, rounding, and brand loyalty. The company also offers marketing experience solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools through a multi-mode digital platform. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; employee experience solutions that give care teams information, tools and support needed to create engagement and open communication throughout the employee lifecycle; and consumer experience solutions which capture feedback across the healthcare journey, drive choice to build volume, and co-design experiences and services through community insights. Additionally, the company offers Huey AI, an AI engine for Human Understanding that serves as a healthcare experience management companion; and governance solutions for not-for-profit health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

Fundamental data was last updated by Penke on 2025-06-18 21:27:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is fair priced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit National Research Corp earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare National Research Corp to the Health Information Services industry mean.
  • A Net Profit Margin of 17.2% means that $0.17 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of National Research Corp:

  • The MRQ is 17.2%. The company is making a huge profit. +2
  • The TTM is 17.1%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ17.2%TTM17.1%+0.1%
TTM17.1%YOY20.5%-3.4%
TTM17.1%5Y21.6%-4.5%
5Y21.6%10Y21.9%-0.3%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ17.2%-10.0%+27.2%
TTM17.1%-16.2%+33.3%
YOY20.5%-12.4%+32.9%
3Y19.3%-22.9%+42.2%
5Y21.6%-19.2%+40.8%
10Y21.9%-30.1%+52.0%
4.3.1.2. Return on Assets

Shows how efficient National Research Corp is using its assets to generate profit.

  • Above 5% is considered healthy but always compare National Research Corp to the Health Information Services industry mean.
  • 4.3% Return on Assets means that National Research Corp generated $0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of National Research Corp:

  • The MRQ is 4.3%. Using its assets, the company is less efficient in making profit.
  • The TTM is 4.7%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.3%TTM4.7%-0.4%
TTM4.7%YOY6.1%-1.4%
TTM4.7%5Y5.8%-1.1%
5Y5.8%10Y5.7%+0.1%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ4.3%-2.6%+6.9%
TTM4.7%-4.3%+9.0%
YOY6.1%-3.5%+9.6%
3Y5.5%-5.3%+10.8%
5Y5.8%-4.8%+10.6%
10Y5.7%-5.5%+11.2%
4.3.1.3. Return on Equity

Shows how efficient National Research Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare National Research Corp to the Health Information Services industry mean.
  • 19.5% Return on Equity means National Research Corp generated $0.20 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of National Research Corp:

  • The MRQ is 19.5%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 18.1%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ19.5%TTM18.1%+1.4%
TTM18.1%YOY14.6%+3.5%
TTM18.1%5Y13.9%+4.2%
5Y13.9%10Y14.9%-1.0%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ19.5%-1.7%+21.2%
TTM18.1%-3.2%+21.3%
YOY14.6%-3.2%+17.8%
3Y14.5%-6.6%+21.1%
5Y13.9%-7.0%+20.9%
10Y14.9%-9.1%+24.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of National Research Corp.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient National Research Corp is operating .

  • Measures how much profit National Research Corp makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare National Research Corp to the Health Information Services industry mean.
  • An Operating Margin of 25.7% means the company generated $0.26  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of National Research Corp:

  • The MRQ is 25.7%. The company is operating very efficient. +2
  • The TTM is 24.8%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ25.7%TTM24.8%+0.9%
TTM24.8%YOY27.3%-2.5%
TTM24.8%5Y29.4%-4.6%
5Y29.4%10Y29.6%-0.2%
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ25.7%-14.2%+39.9%
TTM24.8%-11.4%+36.2%
YOY27.3%-9.1%+36.4%
3Y27.2%-10.0%+37.2%
5Y29.4%-10.5%+39.9%
10Y29.6%-23.4%+53.0%
4.3.2.2. Operating Ratio

Measures how efficient National Research Corp is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Health Information Services industry mean).
  • An Operation Ratio of 0.74 means that the operating costs are $0.74 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of National Research Corp:

  • The MRQ is 0.744. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.752. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.744TTM0.752-0.008
TTM0.752YOY0.731+0.021
TTM0.7525Y0.708+0.044
5Y0.70810Y0.705+0.003
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7441.339-0.595
TTM0.7521.310-0.558
YOY0.7311.338-0.607
3Y0.7301.345-0.615
5Y0.7081.326-0.618
10Y0.7051.298-0.593
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of National Research Corp.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if National Research Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Health Information Services industry mean).
  • A Current Ratio of 0.54 means the company has $0.54 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of National Research Corp:

  • The MRQ is 0.540. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.481. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.540TTM0.481+0.059
TTM0.481YOY0.726-0.245
TTM0.4815Y1.146-0.665
5Y1.14610Y1.187-0.041
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5401.682-1.142
TTM0.4811.609-1.128
YOY0.7261.810-1.084
3Y0.8241.995-1.171
5Y1.1462.617-1.471
10Y1.1872.519-1.332
4.4.3.2. Quick Ratio

Measures if National Research Corp is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare National Research Corp to the Health Information Services industry mean.
  • A Quick Ratio of 0.37 means the company can pay off $0.37 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of National Research Corp:

  • The MRQ is 0.366. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.344. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.366TTM0.344+0.022
TTM0.344YOY0.634-0.290
TTM0.3445Y1.050-0.706
5Y1.05010Y1.091-0.041
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3661.013-0.647
TTM0.3441.074-0.730
YOY0.6341.288-0.654
3Y0.7591.473-0.714
5Y1.0502.041-0.991
10Y1.0912.123-1.032
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of National Research Corp.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of National Research Corp assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare National Research Corp to Health Information Services industry mean.
  • A Debt to Asset Ratio of 0.78 means that National Research Corp assets are financed with 78.0% credit (debt) and the remaining percentage (100% - 78.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of National Research Corp:

  • The MRQ is 0.780. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.736. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.780TTM0.736+0.044
TTM0.736YOY0.558+0.178
TTM0.7365Y0.557+0.179
5Y0.55710Y0.523+0.033
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7800.401+0.379
TTM0.7360.406+0.330
YOY0.5580.373+0.185
3Y0.5880.394+0.194
5Y0.5570.393+0.164
10Y0.5230.402+0.121
4.5.4.2. Debt to Equity Ratio

Measures if National Research Corp is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare National Research Corp to the Health Information Services industry mean.
  • A Debt to Equity ratio of 355.6% means that company has $3.56 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of National Research Corp:

  • The MRQ is 3.556. The company is unable to pay all its debts with equity. -1
  • The TTM is 2.890. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ3.556TTM2.890+0.665
TTM2.890YOY1.392+1.498
TTM2.8905Y1.460+1.431
5Y1.46010Y1.471-0.011
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5560.609+2.947
TTM2.8900.608+2.282
YOY1.3920.571+0.821
3Y1.7260.608+1.118
5Y1.4600.636+0.824
10Y1.4710.636+0.835
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings National Research Corp generates.

  • Above 15 is considered overpriced but always compare National Research Corp to the Health Information Services industry mean.
  • A PE ratio of 12.70 means the investor is paying $12.70 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of National Research Corp:

  • The EOD is 16.416. Based on the earnings, the company is fair priced.
  • The MRQ is 12.704. Based on the earnings, the company is underpriced. +1
  • The TTM is 18.623. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD16.416MRQ12.704+3.712
MRQ12.704TTM18.623-5.919
TTM18.623YOY34.117-15.495
TTM18.6235Y30.428-11.806
5Y30.42810Y24.392+6.036
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD16.416-1.363+17.779
MRQ12.704-1.619+14.323
TTM18.623-1.175+19.798
YOY34.117-1.789+35.906
3Y28.598-2.590+31.188
5Y30.428-3.143+33.571
10Y24.392-2.060+26.452
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of National Research Corp:

  • The EOD is 25.956. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 20.087. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 45.282. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD25.956MRQ20.087+5.869
MRQ20.087TTM45.282-25.196
TTM45.282YOY42.917+2.366
TTM45.2825Y38.913+6.370
5Y38.91310Y35.952+2.961
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD25.956-0.403+26.359
MRQ20.087-0.452+20.539
TTM45.282-1.001+46.283
YOY42.917-1.848+44.765
3Y43.228-4.493+47.721
5Y38.913-5.950+44.863
10Y35.952-4.161+40.113
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of National Research Corp is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Health Information Services industry mean).
  • A PB ratio of 9.91 means the investor is paying $9.91 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of National Research Corp:

  • The EOD is 12.806. Based on the equity, the company is expensive. -2
  • The MRQ is 9.911. Based on the equity, the company is overpriced. -1
  • The TTM is 13.104. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD12.806MRQ9.911+2.896
MRQ9.911TTM13.104-3.194
TTM13.104YOY19.573-6.469
TTM13.1045Y16.421-3.317
5Y16.42110Y19.026-2.605
Compared to industry (Health Information Services)
PeriodCompanyIndustry (mean)+/- 
EOD12.8061.751+11.055
MRQ9.9111.743+8.168
TTM13.1041.761+11.343
YOY19.5732.563+17.010
3Y15.5512.630+12.921
5Y16.4213.510+12.911
10Y19.0264.371+14.655
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of National Research Corp.

4.8.1. Institutions holding National Research Corp

Institutions are holding 51.254% of the shares of National Research Corp.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Kayne Anderson Rudnick Investment Management LLC13.27390.09483024509-8918-0.294
2025-03-31BlackRock Inc4.92250.00031121615-84839-7.0321
2025-03-31Vanguard Group Inc4.09470.0002932986-19678-2.0656
2025-03-31Morgan Stanley - Brokerage Accounts3.74090.0008852390-64673-7.0522
2025-03-31Dimensional Fund Advisors, Inc.2.43260.0018554287-28192-4.84
2025-03-31Geode Capital Management, LLC1.95990.0005446573108662.4939
2025-03-31Renaissance Technologies Corp1.6260.0072370484-34402-8.4967
2025-03-31QV Investors Inc1.55520.45835436000
2025-03-31State Street Corp1.46090.0002332881-25201-7.0378
2025-03-31Northern Trust Corp1.36920.0006311967182126.1997
2025-03-31Bank of New York Mellon Corp0.91810.0005209197-8015-3.6899
2025-03-31Citadel Advisors Llc0.80040.00041823718144980.7049
2025-03-31Hotchkis & Wiley Capital Management LLC0.7020.0068159950-1800-1.1128
2024-12-31Wells Fargo & Co0.62820.0006143145-28693-16.6977
2025-03-31Northwest & Ethical Investments L.P.0.5670.044912920000
2025-03-31Charles Schwab Investment Management Inc0.52460.0003119521-5190-4.1616
2025-03-31Bank of America Corp0.50760.000111565439973.5797
2025-03-31Goldman Sachs Group Inc0.49680.0002113195-11657-9.3367
2025-03-31AQR Capital Management LLC0.47460.001410813467882168.6426
2024-12-31Comerica Bank0.41310.006794137-5651-5.663
Total 42.46820.62639676556-144503-1.5%

4.9.2. Funds holding National Research Corp

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Virtus KAR Small-Cap Growth I8.81271.1517200800900
2025-04-30Vanguard Total Stock Mkt Idx Inv2.58510.000458902200
2025-03-31Virtus GF US Small Cap Focus I USD Acc1.91451.45443623500
2025-05-31iShares Russell 2000 ETF1.59810.00836413800
2025-04-30Vanguard Institutional Extnd Mkt Idx Tr0.94160.002421455200
2025-04-30DFA US Micro Cap I0.83580.035919044300
2025-04-30IA Clarington Canadian Small Cap A0.8230.355518752000
2025-03-31Fidelity Small Cap Index0.67390.008115354012410.8148
2025-05-31iShares Russell 2000 Growth ETF0.59650.016613590600
2025-04-30NEI Canadian Small Cap Equity RS A0.5670.330612920000
2025-05-30WisdomTree US SmallCap Dividend ETF0.49320.0839112381-192-0.1706
2025-04-30DFA US Small Cap I0.43740.007699670-2576-2.5194
2025-05-31State St Russell Sm/Mid Cp® Indx SL Cl I0.41130.00319371500
2025-04-30Fidelity Extended Market Index0.35430.002680719-772-0.9473
2025-03-31JNL Multi-Manager Small Cap Growth A0.34240.047778027-7500-8.7692
2025-04-30Vanguard Russell 2000 ETF0.32650.00727438542776.1006
2025-05-31Schwab US Small-Cap ETF™0.30990.005870606-185-0.2613
2025-04-30KAR Small Cap Growth CIT C10.29240.66646662300
2025-05-31QV Global Small Cap Fund0.28352.0418645902695071.5994
2025-04-30Hotchkis & Wiley Sm Cp Divers Val I0.27610.1072629002570069.086
Total 22.87526.33655212181+46943+0.9%

5.3. Insider Transactions

Insiders are holding 46.971% of the shares of National Research Corp.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-05-12Patrick E BeansBUY250013.59
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets135,175
Total Liabilities105,503
Total Stockholder Equity29,672
 As reported
Total Liabilities 105,503
Total Stockholder Equity+ 29,672
Total Assets = 135,175

Assets

Total Assets135,175
Total Current Assets20,402
Long-term Assets114,773
Total Current Assets
Cash And Cash Equivalents 2,502
Net Receivables 11,326
Other Current Assets 12,419
Total Current Assets  (as reported)20,402
Total Current Assets  (calculated)26,247
+/- 5,845
Long-term Assets
Property Plant Equipment 40,390
Goodwill 66,152
Intangible Assets 2,519
Long-term Assets Other 8,231
Long-term Assets  (as reported)114,773
Long-term Assets  (calculated)117,292
+/- 2,519

Liabilities & Shareholders' Equity

Total Current Liabilities37,774
Long-term Liabilities67,729
Total Stockholder Equity29,672
Total Current Liabilities
Short-term Debt 6,536
Short Long Term Debt 6,536
Accounts payable 2,030
Other Current Liabilities 16,436
Total Current Liabilities  (as reported)37,774
Total Current Liabilities  (calculated)31,538
+/- 6,236
Long-term Liabilities
Long term Debt 58,669
Long-term Liabilities Other 3,669
Long-term Liabilities  (as reported)67,729
Long-term Liabilities  (calculated)62,338
+/- 5,391
Total Stockholder Equity
Common Stock31
Retained Earnings -14,012
Other Stockholders Equity 43,653
Total Stockholder Equity (as reported)29,672
Total Stockholder Equity (calculated)29,672
+/-0
Other
Capital Stock31
Cash and Short Term Investments 2,502
Common Stock Shares Outstanding 22,974
Current Deferred Revenue15,507
Liabilities and Stockholders Equity 135,175
Net Debt 62,703
Net Invested Capital 94,877
Net Working Capital -17,372
Property Plant and Equipment Gross 78,715
Short Long Term Debt Total 65,205



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-31
> Total Assets 
0
0
0
22,600
23,100
25,400
24,200
26,300
25,900
25,300
27,200
29,300
30,527
32,005
32,323
31,637
31,896
33,088
33,198
33,772
34,166
35,910
37,261
38,832
41,848
43,159
43,375
45,673
46,262
46,595
46,228
47,954
48,708
48,365
49,226
44,675
44,222
61,747
60,265
61,532
62,524
63,292
64,041
61,869
62,194
61,169
60,764
72,145
73,334
72,264
74,406
72,499
77,384
78,824
93,400
95,770
98,003
100,298
100,952
100,676
103,378
105,594
109,429
100,046
103,502
104,899
109,914
110,996
116,277
121,868
127,063
129,510
128,452
131,048
129,476
129,099
118,370
116,499
119,301
120,624
126,059
124,576
128,740
127,316
130,976
102,885
108,717
107,684
104,571
104,275
107,649
110,685
115,855
116,781
127,246
133,423
146,878
151,849
156,186
157,540
153,154
136,233
134,983
130,461
134,306
133,627
120,136
122,437
120,911
119,099
131,798
132,539
135,175
135,175132,539131,798119,099120,911122,437120,136133,627134,306130,461134,983136,233153,154157,540156,186151,849146,878133,423127,246116,781115,855110,685107,649104,275104,571107,684108,717102,885130,976127,316128,740124,576126,059120,624119,301116,499118,370129,099129,476131,048128,452129,510127,063121,868116,277110,996109,914104,899103,502100,046109,429105,594103,378100,676100,952100,29898,00395,77093,40078,82477,38472,49974,40672,26473,33472,14560,76461,16962,19461,86964,04163,29262,52461,53260,26561,74744,22244,67549,22648,36548,70847,95446,22846,59546,26245,67343,37543,15941,84838,83237,26135,91034,16633,77233,19833,08831,89631,63732,32332,00530,52729,30027,20025,30025,90026,30024,20025,40023,10022,600000
   > Total Current Assets 
0
0
0
21,900
22,200
20,000
17,800
17,300
15,000
13,900
14,700
15,800
15,391
15,609
14,111
13,250
13,898
11,136
11,297
12,292
12,964
14,773
16,168
17,948
19,496
20,808
21,213
23,521
23,504
23,813
23,683
25,454
26,406
26,291
23,087
18,218
17,870
12,814
11,672
12,997
13,931
14,385
15,117
12,600
13,583
12,282
11,954
10,439
12,707
11,019
13,324
11,664
17,226
19,513
16,365
17,341
20,181
20,845
21,627
22,137
25,259
28,224
32,451
23,815
27,869
29,665
34,908
36,474
42,275
47,475
53,202
53,188
53,171
55,771
56,067
56,111
44,814
42,741
45,917
47,065
52,383
50,983
53,822
52,259
52,278
23,633
28,770
28,062
22,873
22,888
26,570
29,157
34,939
36,697
47,366
54,112
62,235
67,589
72,726
73,707
68,921
51,780
49,105
43,716
45,172
40,987
24,743
24,360
20,014
16,950
20,700
19,600
20,402
20,40219,60020,70016,95020,01424,36024,74340,98745,17243,71649,10551,78068,92173,70772,72667,58962,23554,11247,36636,69734,93929,15726,57022,88822,87328,06228,77023,63352,27852,25953,82250,98352,38347,06545,91742,74144,81456,11156,06755,77153,17153,18853,20247,47542,27536,47434,90829,66527,86923,81532,45128,22425,25922,13721,62720,84520,18117,34116,36519,51317,22611,66413,32411,01912,70710,43911,95412,28213,58312,60015,11714,38513,93112,99711,67212,81417,87018,21823,08726,29126,40625,45423,68323,81323,50423,52121,21320,80819,49617,94816,16814,77312,96412,29211,29711,13613,89813,25014,11115,60915,39115,80014,70013,90015,00017,30017,80020,00022,20021,900000
       Cash And Cash Equivalents 
0
0
0
4,700
3,900
1,400
900
4,900
2,200
2,500
1,100
1,100
330
3,724
4,912
3,219
2,673
1,137
2,924
1,080
1,233
1,870
1,658
991
1,257
2,698
3,947
3,441
5,226
3,942
2,543
3,648
5,326
3,125
1,036
844
1,031
575
1,387
876
1,358
2,122
2,059
3,355
1,486
1,309
677
1,109
620
404
1,460
2,512
6,261
7,236
3,195
3,519
3,316
4,464
6,223
8,082
7,872
11,168
15,026
8,286
9,234
10,802
18,934
22,092
26,453
31,539
39,063
40,042
37,010
40,555
37,580
42,145
25,366
27,192
28,878
33,021
34,664
31,628
35,750
34,733
35,478
6,698
7,273
12,991
2,641
4,020
8,358
13,517
10,021
11,957
21,855
34,690
43,454
48,899
52,482
54,361
47,290
32,974
28,392
25,026
23,724
22,496
3,828
6,653
1,699
485
3,461
4,233
2,502
2,5024,2333,4614851,6996,6533,82822,49623,72425,02628,39232,97447,29054,36152,48248,89943,45434,69021,85511,95710,02113,5178,3584,0202,64112,9917,2736,69835,47834,73335,75031,62834,66433,02128,87827,19225,36642,14537,58040,55537,01040,04239,06331,53926,45322,09218,93410,8029,2348,28615,02611,1687,8728,0826,2234,4643,3163,5193,1957,2366,2612,5121,4604046201,1096771,3091,4863,3552,0592,1221,3588761,3875751,0318441,0363,1255,3263,6482,5433,9425,2263,4413,9472,6981,2579911,6581,8701,2331,0802,9241,1372,6733,2194,9123,7243301,1001,1002,5002,2004,9009001,4003,9004,700000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
7,300
10,700
10,900
11,753
7,624
5,990
6,577
7,718
6,027
5,025
6,637
7,124
7,435
8,932
9,987
10,858
11,089
12,155
12,766
12,515
13,338
14,597
15,348
15,019
15,563
14,641
9,452
8,692
1,677
1,243
1,110
1,028
753
497
99
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,692
0
8,692
8,692
8,692
0
0
0
0
0
0
0
00000008,6928,6928,69208,692000000000000000000000000000000000000000000000000000000001994977531,0281,1101,2431,6778,6929,45214,64115,56315,01915,34814,59713,33812,51512,76612,15511,08910,8589,9878,9327,4357,1246,6375,0256,0277,7186,5775,9907,62411,75310,90010,7007,300000000000
       Net Receivables 
0
0
0
3,100
2,000
5,400
4,300
4,000
3,600
2,200
2,100
3,500
1,874
3,366
1,656
2,961
2,948
2,899
1,596
2,141
3,969
2,338
5,122
4,579
6,550
5,302
2,552
5,479
3,418
3,790
5,373
3,392
4,559
4,553
6,404
6,677
7,272
9,072
7,993
9,904
10,294
9,839
11,565
8,029
10,791
9,803
10,194
6,531
9,594
7,395
8,385
5,214
8,113
7,902
9,779
9,172
14,080
12,387
12,650
12,100
14,576
14,724
15,182
12,277
15,930
16,252
13,500
11,308
12,283
13,172
11,080
9,216
13,126
11,745
13,997
9,965
15,519
12,910
15,428
10,878
15,471
15,954
14,932
15,181
14,374
12,402
16,612
11,922
16,205
15,954
15,864
11,708
20,754
20,002
17,667
14,234
14,562
14,307
16,434
13,827
15,983
13,565
15,397
14,563
14,330
12,168
14,808
12,539
11,204
10,340
11,704
11,195
11,326
11,32611,19511,70410,34011,20412,53914,80812,16814,33014,56315,39713,56515,98313,82716,43414,30714,56214,23417,66720,00220,75411,70815,86415,95416,20511,92216,61212,40214,37415,18114,93215,95415,47110,87815,42812,91015,5199,96513,99711,74513,1269,21611,08013,17212,28311,30813,50016,25215,93012,27715,18214,72414,57612,10012,65012,38714,0809,1729,7797,9028,1135,2148,3857,3959,5946,53110,1949,80310,7918,02911,5659,83910,2949,9047,9939,0727,2726,6776,4044,5534,5593,3925,3733,7903,4185,4792,5525,3026,5504,5795,1222,3383,9692,1411,5962,8992,9482,9611,6563,3661,8743,5002,1002,2003,6004,0004,3005,4002,0003,100000
       Other Current Assets 
0
0
0
14,100
16,300
13,200
12,600
8,400
9,200
1,900
800
300
1,432
896
1,553
493
561
1,073
1,752
497
639
3,131
456
2,391
831
1,719
2,559
1,835
2,345
2,742
1,169
3,066
1,502
3,049
1,006
1,244
875
1,491
1,049
1,107
1,252
1,671
996
1,117
1,306
1,170
1,083
2,799
2,493
3,221
3,451
3,938
2,852
4,225
3,419
4,650
2,785
3,994
2,754
1,955
2,811
2,332
2,243
3,252
2,705
2,356
2,474
3,074
3,539
2,764
3,059
3,930
3,035
3,471
4,490
4,001
3,929
2,639
1,623
3,166
2,248
3,401
3,140
2,720
2,426
4,533
4,885
3,149
421
218
2,348
3,932
7,399
4,738
7,844
5,188
4,219
4,383
3,810
5,519
5,648
5,241
5,316
4,127
7,118
6,388
6,107
5,168
7,111
6,125
5,535
4,172
12,419
12,4194,1725,5356,1257,1115,1686,1076,3887,1184,1275,3165,2415,6485,5193,8104,3834,2195,1887,8444,7387,3993,9322,3482184213,1494,8854,5332,4262,7203,1403,4012,2483,1661,6232,6393,9294,0014,4903,4713,0353,9303,0592,7643,5393,0742,4742,3562,7053,2522,2432,3322,8111,9552,7543,9942,7854,6503,4194,2252,8523,9383,4513,2212,4932,7991,0831,1701,3061,1179961,6711,2521,1071,0491,4918751,2441,0063,0491,5023,0661,1692,7422,3451,8352,5591,7198312,3914563,1316394971,7521,0735614931,5538961,4323008001,9009,2008,40012,60013,20016,30014,100000
   > Long-term Assets 
0
0
0
700
900
5,400
6,400
9,000
10,900
11,400
12,500
13,500
15,137
16,396
18,212
18,388
17,998
21,952
21,901
0
21,202
21,137
21,093
20,884
22,352
22,350
22,163
22,152
22,758
22,783
22,544
22,500
22,302
22,075
26,138
26,457
26,352
48,932
48,594
0
48,592
48,907
48,924
49,268
48,611
48,888
48,810
61,706
60,627
61,245
61,082
60,835
60,158
59,311
77,035
78,429
77,822
79,453
79,325
78,539
78,119
77,370
76,978
76,231
75,633
75,234
75,006
74,522
74,002
74,393
73,861
76,322
75,281
75,277
73,409
72,988
73,556
73,758
73,384
73,559
73,676
73,593
74,918
75,057
78,698
79,252
79,947
79,622
81,698
81,387
81,079
81,528
80,916
80,084
79,880
79,311
84,643
84,260
83,460
83,833
84,233
84,453
85,878
86,745
89,134
92,640
95,393
98,077
100,897
102,149
111,098
112,939
114,773
114,773112,939111,098102,149100,89798,07795,39392,64089,13486,74585,87884,45384,23383,83383,46084,26084,64379,31179,88080,08480,91681,52881,07981,38781,69879,62279,94779,25278,69875,05774,91873,59373,67673,55973,38473,75873,55672,98873,40975,27775,28176,32273,86174,39374,00274,52275,00675,23475,63376,23176,97877,37078,11978,53979,32579,45377,82278,42977,03559,31160,15860,83561,08261,24560,62761,70648,81048,88848,61149,26848,92448,90748,592048,59448,93226,35226,45726,13822,07522,30222,50022,54422,78322,75822,15222,16322,35022,35220,88421,09321,13721,202021,90121,95217,99818,38818,21216,39615,13713,50012,50011,40010,9009,0006,4005,400900700000
       Property Plant Equipment 
0
0
0
500
700
1,300
1,700
2,300
4,300
5,000
6,100
7,500
9,354
10,761
12,677
13,218
12,941
13,016
13,137
12,907
12,661
12,628
12,553
12,346
12,419
12,398
12,250
12,189
12,827
12,887
12,669
12,355
12,176
11,992
11,884
11,891
11,860
11,949
11,807
11,716
11,686
11,634
11,523
11,974
12,231
12,385
12,595
13,747
13,693
14,403
14,233
13,975
13,503
13,031
14,372
14,482
14,227
13,804
13,888
13,613
13,511
13,124
12,907
12,493
12,192
12,089
12,040
11,898
11,725
12,179
11,943
12,143
11,604
11,743
11,161
11,125
11,631
11,843
11,659
11,806
12,133
12,138
12,089
12,359
12,456
13,320
14,269
14,153
16,108
15,857
13,696
13,530
12,655
13,667
12,267
11,726
12,845
11,525
12,506
12,391
13,767
14,389
16,422
17,248
19,936
22,953
26,752
30,265
33,467
35,547
36,320
39,896
40,390
40,39039,89636,32035,54733,46730,26526,75222,95319,93617,24816,42214,38913,76712,39112,50611,52512,84511,72612,26713,66712,65513,53013,69615,85716,10814,15314,26913,32012,45612,35912,08912,13812,13311,80611,65911,84311,63111,12511,16111,74311,60412,14311,94312,17911,72511,89812,04012,08912,19212,49312,90713,12413,51113,61313,88813,80414,22714,48214,37213,03113,50313,97514,23314,40313,69313,74712,59512,38512,23111,97411,52311,63411,68611,71611,80711,94911,86011,89111,88411,99212,17612,35512,66912,88712,82712,18912,25012,39812,41912,34612,55312,62812,66112,90713,13713,01612,94113,21812,67710,7619,3547,5006,1005,0004,3002,3001,7001,300700500000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,908
0
0
7,889
9,080
9,110
9,109
8,002
8,997
8,997
8,997
8,293,346
8,277,784
8,262,414
11,900,902
11,483,401
11,481
30,044
30,055
30,014
30,254
30,751
31,017
31,051
30,927
30,962
30,882
39,276
38,543
38,739
38,982
39,924
40,010
39,927
53,139
55,133
55,170
57,589
57,693
57,730
57,798
57,715
57,839
57,799
57,736
57,638
57,698
57,592
57,499
57,599
57,475
58,489
58,280
58,336
57,867
57,792
57,944
57,946
57,913
57,861
57,881
57,942
58,036
58,021
57,956
57,913
57,955
57,831
57,877
57,922
57,896
57,935
57,746
57,829
57,875
57,255
61,614
61,640
61,614
61,614
61,614
61,614
61,614
61,614
61,614
61,614
61,614
61,614
61,614
61,614
66,209
66,152
66,152
66,15266,15266,20961,61461,61461,61461,61461,61461,61461,61461,61461,61461,61461,61461,61461,64061,61457,25557,87557,82957,74657,93557,89657,92257,87757,83157,95557,91357,95658,02158,03657,94257,88157,86157,91357,94657,94457,79257,86758,33658,28058,48957,47557,59957,49957,59257,69857,63857,73657,79957,83957,71557,79857,73057,69357,58955,17055,13353,13939,92740,01039,92438,98238,73938,54339,27630,88230,96230,92731,05131,01730,75130,25430,01430,05530,04411,48111,483,40111,900,9028,262,4148,277,7848,293,3468,9978,9978,9978,0029,1099,1109,0807,889007,90800000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,300
0
0
0
1,300
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000001,3000001,300000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
2,800
3,300
6,200
6,100
6,000
5,900
5,400
5,358
5,192
5,110
5,058
4,984
8,906
8,720
8,539
8,539
8,478
8,511
8,496
9,886
9,110
9,110
9,940
9,909
9,875
9,856
10,126
10,079
10,033
14,206
14,527
2,976
6,891
6,684
6,474
6,252
6,043
5,831
5,616
5,406
5,484
5,272
8,056
7,746
7,459
7,171
6,883
6,595
6,307
9,467
8,638
8,239
7,848
7,460
7,073
6,685
6,335
6,063
5,794
5,528
5,274
5,050
4,840
4,630
4,419
4,209
5,457
5,194
4,932
3,969
3,778
3,592
3,418
3,271
3,124
2,977
2,830
2,932
2,764
2,596
2,428
2,260
2,102
2,008
1,915
1,822
1,728
1,635
1,541
1,462
1,410
2,024
1,937
1,851
1,790
1,743
1,696
1,650
1,611
1,576
1,541
1,506
1,471
1,436
1,401
2,713
2,616
2,519
2,5192,6162,7131,4011,4361,4711,5061,5411,5761,6111,6501,6961,7431,7901,8511,9372,0241,4101,4621,5411,6351,7281,8221,9152,0082,1022,2602,4282,5962,7642,9322,8302,9773,1243,2713,4183,5923,7783,9694,9325,1945,4574,2094,4194,6304,8405,0505,2745,5285,7946,0636,3356,6857,0737,4607,8488,2398,6389,4676,3076,5956,8837,1717,4597,7468,0565,2725,4845,4065,6165,8316,0436,2526,4746,6846,8912,97614,52714,20610,03310,07910,1269,8569,8759,9099,9409,1109,1109,8868,4968,5118,4788,5398,5398,7208,9064,9845,0585,1105,1925,3585,4005,9006,0006,1006,2003,3002,80000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
5,783
5,635
5,535
5,169
5,057
8,935
8,764
8,573
8,541
8,509
8,540
8,538
9,934
9,952
9,912
9,963
9,931
9,896
9,876
10,144
10,126
10,082
14,255
14,566
14,492
36,984
36,786
36,819
36,906
37,273
37,401
37,295
36,380
36,502
36,215
47,959
46,934
46,842
46,797
46,860
46,655
46,430
62,651
63,947
63,595
65,649
65,437
64,926
64,608
64,246
64,071
63,738
63,441
63,145
62,966
62,624
62,277
62,214
61,918
64,179
63,677
63,534
62,248
61,863
61,925
61,915
61,725
61,753
61,543
61,455
62,829
62,698
5,690
5,591
5,463
4,236
5,705
5,693
5,860
5,407
7,420
7,047
7,063
8,920
0
11,095
10,399
9,828
7,109
9,237
8,503
5,716
6,008
0
0
0
0
0
0
-6,622
0
0-6,6220000006,0085,7168,5039,2377,1099,82810,39911,09508,9207,0637,0477,4205,4075,8605,6935,7054,2365,4635,5915,69062,69862,82961,45561,54361,75361,72561,91561,92561,86362,24863,53463,67764,17961,91862,21462,27762,62462,96663,14563,44163,73864,07164,24664,60864,92665,43765,64963,59563,94762,65146,43046,65546,86046,79746,84246,93447,95936,21536,50236,38037,29537,40137,27336,90636,81936,78636,98414,49214,56614,25510,08210,12610,1449,8769,8969,9319,9639,9129,9529,9348,5388,5408,5098,5418,5738,7648,9355,0575,1695,5355,6355,783000000000000
> Total Liabilities 
0
0
0
4,500
4,400
8,100
6,300
8,900
8,500
7,800
9,100
10,700
11,461
12,248
11,682
10,255
9,922
11,051
10,182
10,419
10,494
11,050
10,738
10,814
12,865
13,255
12,152
13,249
13,731
13,809
12,586
12,936
13,696
15,851
15,081
12,082
10,372
26,674
23,942
24,781
24,523
23,842
22,427
19,582
24,826
22,768
21,156
33,546
33,140
30,964
31,835
28,328
31,280
32,456
45,718
47,186
46,867
47,754
47,442
45,122
44,971
44,531
45,360
43,304
43,555
41,664
42,376
39,241
38,958
39,790
40,755
41,762
40,609
41,353
42,886
54,877
42,200
36,841
38,076
37,818
40,487
36,746
39,896
37,275
35,612
76,068
78,578
88,601
81,832
78,308
78,674
77,793
78,558
71,207
70,517
69,108
73,628
75,484
73,058
72,203
71,668
67,609
67,217
58,428
59,641
55,877
62,264
73,482
83,966
78,901
97,175
101,255
105,503
105,503101,25597,17578,90183,96673,48262,26455,87759,64158,42867,21767,60971,66872,20373,05875,48473,62869,10870,51771,20778,55877,79378,67478,30881,83288,60178,57876,06835,61237,27539,89636,74640,48737,81838,07636,84142,20054,87742,88641,35340,60941,76240,75539,79038,95839,24142,37641,66443,55543,30445,36044,53144,97145,12247,44247,75446,86747,18645,71832,45631,28028,32831,83530,96433,14033,54621,15622,76824,82619,58222,42723,84224,52324,78123,94226,67410,37212,08215,08115,85113,69612,93612,58613,80913,73113,24912,15213,25512,86510,81410,73811,05010,49410,41910,18211,0519,92210,25511,68212,24811,46110,7009,1007,8008,5008,9006,3008,1004,4004,500000
   > Total Current Liabilities 
0
0
0
4,200
4,100
7,400
5,600
8,300
8,100
7,400
8,700
10,600
11,370
12,156
6,271
4,908
4,608
5,804
4,963
5,032
5,042
5,584
5,247
5,030
6,630
6,953
5,813
6,704
7,304
7,433
6,112
6,020
6,834
9,032
8,284
10,160
8,514
16,733
14,427
14,479
14,379
14,801
15,439
14,984
22,179
20,616
18,818
21,089
21,052
19,040
19,240
16,095
19,408
20,739
25,263
26,150
25,727
27,147
26,656
24,399
24,417
25,272
37,687
35,298
35,748
24,742
26,127
23,690
23,938
25,287
26,987
27,926
27,594
29,282
31,584
44,171
32,518
29,270
31,131
31,514
34,351
30,851
34,167
32,310
29,484
32,917
35,437
46,761
39,238
37,076
38,312
38,155
39,879
32,268
32,073
31,681
36,938
39,979
39,170
40,388
41,569
39,587
41,084
33,417
36,112
33,736
40,805
36,203
48,850
45,728
44,277
35,858
37,774
37,77435,85844,27745,72848,85036,20340,80533,73636,11233,41741,08439,58741,56940,38839,17039,97936,93831,68132,07332,26839,87938,15538,31237,07639,23846,76135,43732,91729,48432,31034,16730,85134,35131,51431,13129,27032,51844,17131,58429,28227,59427,92626,98725,28723,93823,69026,12724,74235,74835,29837,68725,27224,41724,39926,65627,14725,72726,15025,26320,73919,40816,09519,24019,04021,05221,08918,81820,61622,17914,98415,43914,80114,37914,47914,42716,7338,51410,1608,2849,0326,8346,0206,1127,4337,3046,7045,8136,9536,6305,0305,2475,5845,0425,0324,9635,8044,6084,9086,27112,15611,37010,6008,7007,4008,1008,3005,6007,4004,1004,200000
       Short-term Debt 
0
0
0
0
0
0
0
0
1,500
0
2,000
3,600
4,058
5,715
392
135
135
131
127
132
128
128
128
132
133
136
139
142
146
149
153
156
159
162
166
1,471
200
4,339
3,001
3,110
727
686
1,036
1,093
6,266
3,256
239
4,581
2,821
820
765
783
808
819
1,809
1,827
1,843
3,260
1,878
1,962
2,072
2,093
13,076
12,436
12,215
2,511
2,348
2,256
2,273
2,465
2,310
2,328
2,467
2,477
2,462
2,402
2,488
2,522
2,542
2,683
2,701
2,311
1,867
1,138
106
3,749
4,027
3,667
5,464
4,890
4,133
4,378
5,331
4,564
4,281
5,015
5,018
5,255
4,518
5,241
4,333
4,390
4,434
5,324
4,546
4,606
9,665
8,420
14,504
17,250
8,721
4,789
6,536
6,5364,7898,72117,25014,5048,4209,6654,6064,5465,3244,4344,3904,3335,2414,5185,2555,0185,0154,2814,5645,3314,3784,1334,8905,4643,6674,0273,7491061,1381,8672,3112,7012,6832,5422,5222,4882,4022,4622,4772,4672,3282,3102,4652,2732,2562,3482,51112,21512,43613,0762,0932,0721,9621,8783,2601,8431,8271,8098198087837658202,8214,5812393,2566,2661,0931,0366867273,1103,0014,3392001,4711661621591561531491461421391361331321281281281321271311351353925,7154,0583,6002,00001,50000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,328
0
0
0
2,402
0
0
0
2,683
2,825
2,209
1,693
1,067
53
3,575
3,623
3,667
5,464
4,890
4,133
4,378
4,631
3,966
4,008
4,061
4,113
4,168
4,223
4,278
4,333
4,390
4,434
4,491
4,546
4,606
9,665
7,214
14,504
16,566
8,721
4,789
6,536
6,5364,7898,72116,56614,5047,2149,6654,6064,5464,4914,4344,3904,3334,2784,2234,1684,1134,0614,0083,9664,6314,3784,1334,8905,4643,6673,6233,575531,0671,6932,2092,8252,6830002,4020002,32800000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
600
900
1,800
1,300
700
1,700
2,000
2,600
1,700
2,552
1,815
2,434
1,771
1,388
1,479
1,559
1,391
1,312
560
401
566
591
640
659
548
954
702
617
430
654
872
803
1,066
6,404
10,423
8,340
1,153
11,493
12,117
11,254
11,028
13,222
14,545
1,041
863
1,181
1,056
1,025
598
794
564
1,087
956
703
870
1,316
783
1,075
770
503
2,658
1,298
1,146
818
654
674
923
3,498
6,028
721
1,358
1,221
21,834
1,572
732
705
3,916
817
883
548
593
724
1,362
839
3,651
1,530
1,186
4,281
4,913
655
957
725
1,095
1,027
338
961
1,943
1,134
1,658
1,056
1,153
1,378
2,152
1,424
1,301
2,397
1,239
2,588
1,194
2,030
2,0301,1942,5881,2392,3971,3011,4242,1521,3781,1531,0561,6581,1341,9439613381,0271,0957259576554,9134,2811,1861,5303,6518391,3627245935488838173,9167057321,57221,8341,2211,3587216,0283,4989236746548181,1461,2982,6585037701,0757831,3168707039561,0875647945981,0251,0561,1818631,04114,54513,22211,02811,25412,11711,4931,1538,34010,4236,4041,0668038726544306177029545486596405915664015601,3121,3911,5591,4791,3881,7712,4341,8152,5521,7002,6002,0001,7007001,3001,800900600000
       Other Current Liabilities 
0
0
0
3,600
3,200
5,600
4,300
7,600
4,900
5,400
4,100
5,300
4,759
4,626
3,444
3,002
3,085
4,195
3,278
3,509
1,017
4,896
1,733
1,055
1,624
1,342
1,775
-242,047
-645,802
-268,930
-592,697
-630,629
-335,272
-239,544
-473,983
-181,781
-206,524
-93,931
-996,538
10,216
-27,189
-53,748
-839,740
-269,356
-563,084
-83,542
-52,420
-558,031
16,751
-670,037
16,368
2,004
3,293
2,122
3,189
4,389
4,118
5,057
5,039
21,509
4,756
4,996
6,581
4,392
5,353
5,322
6,445
6,895
6,251
5,729
4,196
4,475
8,923
8,475
10,447
5,092
13,950
13,287
16,899
9,418
10,081
10,922
11,404
20,805
10,824
11,049
19,202
23,199
14,003
14,012
10,765
12,216
14,782
10,164
9,739
10,940
13,147
18,113
16,214
16,954
16,853
17,485
17,911
12,575
12,641
12,150
12,848
11,426
12,819
12,725
15,667
13,726
16,436
16,43613,72615,66712,72512,81911,42612,84812,15012,64112,57517,91117,48516,85316,95416,21418,11313,14710,9409,73910,16414,78212,21610,76514,01214,00323,19919,20211,04910,82420,80511,40410,92210,0819,41816,89913,28713,9505,09210,4478,4758,9234,4754,1965,7296,2516,8956,4455,3225,3534,3926,5814,9964,75621,5095,0395,0574,1184,3893,1892,1223,2932,00416,368-670,03716,751-558,031-52,420-83,542-563,084-269,356-839,740-53,748-27,18910,216-996,538-93,931-206,524-181,781-473,983-239,544-335,272-630,629-592,697-268,930-645,802-242,0471,7751,3421,6241,0551,7334,8961,0173,5093,2784,1953,0853,0023,4444,6264,7595,3004,1005,4004,9007,6004,3005,6003,2003,600000
   > Long-term Liabilities 
0
0
0
300
300
700
700
600
400
400
400
100
91
92
5,411
5,347
5,314
5,247
5,219
0
5,452
5,466
5,491
5,784
6,235
6,303
6,339
6,545
6,427
6,376
6,474
6,917
6,862
6,820
6,797
1,922
1,858
9,942
9,514
0
10,144
9,041
6,988
4,598
2,647
2,153
2,339
12,457
12,088
11,924
12,595
12,233
11,872
11,717
20,455
21,036
21,140
20,607
20,786
20,723
20,554
19,259
7,673
8,006
7,807
16,922
16,249
15,551
15,020
14,503
13,768
13,836
13,015
12,071
11,302
10,706
9,682
7,571
6,945
6,304
6,136
5,895
5,729
4,965
6,128
43,151
43,141
41,840
42,594
41,232
40,362
39,638
38,679
38,939
38,444
37,427
36,690
35,505
33,888
31,815
30,099
28,022
26,133
25,011
23,529
22,141
21,459
37,279
35,116
33,173
52,898
65,397
67,729
67,72965,39752,89833,17335,11637,27921,45922,14123,52925,01126,13328,02230,09931,81533,88835,50536,69037,42738,44438,93938,67939,63840,36241,23242,59441,84043,14143,1516,1284,9655,7295,8956,1366,3046,9457,5719,68210,70611,30212,07113,01513,83613,76814,50315,02015,55116,24916,9227,8078,0067,67319,25920,55420,72320,78620,60721,14021,03620,45511,71711,87212,23312,59511,92412,08812,4572,3392,1532,6474,5986,9889,04110,14409,5149,9421,8581,9226,7976,8206,8626,9176,4746,3766,4276,5456,3396,3036,2355,7845,4915,4665,45205,2195,2475,3145,3475,4119291100400400400600700700300300000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,392
12,916
0
0
0
0
225
0
9,203
8,638
8,176
7,568
6,912
6,328
5,740
5,146
0
3,945
3,337
2,724
0
0
857
225
0
0
0
0
0
0
34,176
33,840
32,794
31,606
30,354
28,593
28,627
0
0
25,494
0
23,360
22,269
0
20,044
0
17,690
16,530
15,358
0
0
0
0
0
0
0
000000015,35816,53017,690020,044022,26923,360025,4940028,62728,59330,35431,60632,79433,84034,176000000225857002,7243,3373,94505,1465,7406,3286,9127,5688,1768,6389,2030225000012,91613,392000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
79
79
79
51
51
12
12
0
0
0
0
0
408
446
443
464
459
447
473
344
341
338
355
0
0
0
0
52
274
589
706
0
0
0
0
0
0
0
0
204
216
262
208
183
563
514
512
185
672
627
579
254
603
512
434
243
202
594
535
497
598
584
546
472
438
546
559
476
838
838
874
848
6,128
7,122
8,032
7,664
7,265
7,077
7,508
8,145
8,570
8,488
8,330
10,880
11,196
11,071
10,528
9,546
0
7,978
7,296
6,949
6,999
0
0
0
0
0
0
0
0
000000006,9996,9497,2967,97809,54610,52811,07111,19610,8808,3308,4888,5708,1457,5087,0777,2657,6648,0327,1226,128848874838838476559546438472546584598497535594202243434512603254579627672185512514563183208262216204000000007065892745200003553383413444734474594644434464080000012125151797979000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,935
7,565
0
0
0
0
7,781
7,609
7,551
7,473
7,375
7,452
7,160
7,028
7,555
63
6,983
24
6,798
6,520
0
0
0
0
0
4,855
0
5,153
3,369
3,371
3,484
3,642
3,743
3,993
4,204
7,704
4,582
4,542
4,555
7,405
4,642
7,151
3,772
6,507
3,167
2,784
5,274
4,894
0
0
0
0
0
0
0
0
000000004,8945,2742,7843,1676,5073,7727,1514,6427,4054,5554,5424,5827,7044,2043,9933,7433,6423,4843,3713,3695,15304,855000006,5206,798246,983637,5557,0287,1607,4527,3757,4737,5517,6097,78100007,5656,935000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
18,100
18,700
17,300
17,900
17,400
17,400
17,500
18,100
18,600
19,066
19,757
20,642
21,382
21,974
22,037
23,015
23,353
23,672
24,860
26,523
28,018
28,983
29,904
31,224
32,424
32,531
32,786
33,641
35,018
35,012
32,514
34,144
32,593
33,850
35,072
36,324
36,750
38,001
39,450
41,614
42,286
37,368
38,401
39,607
38,598
40,194
41,300
42,571
44,171
46,104
46,368
47,682
48,584
51,136
52,544
53,510
55,554
58,407
61,063
64,069
56,742
59,947
63,235
67,538
71,755
77,319
82,078
86,308
87,748
87,843
89,695
86,590
74,222
76,170
79,658
81,225
82,806
85,572
87,830
88,844
90,041
95,364
26,817
30,139
19,083
22,739
25,967
28,975
32,892
37,297
45,574
56,729
64,315
73,250
76,365
83,128
85,337
81,486
68,624
67,766
72,033
74,665
77,750
57,872
48,955
36,945
40,198
34,623
31,284
29,672
29,67231,28434,62340,19836,94548,95557,87277,75074,66572,03367,76668,62481,48685,33783,12876,36573,25064,31556,72945,57437,29732,89228,97525,96722,73919,08330,13926,81795,36490,04188,84487,83085,57282,80681,22579,65876,17074,22286,59089,69587,84387,74886,30882,07877,31971,75567,53863,23559,94756,74264,06961,06358,40755,55453,51052,54451,13648,58447,68246,36846,10444,17142,57141,30040,19438,59839,60738,40137,36842,28641,61439,45038,00136,75036,32435,07233,85032,59334,14432,51435,01235,01833,64132,78632,53132,42431,22429,90428,98328,01826,52324,86023,67223,35323,01522,03721,97421,38220,64219,75719,06618,60018,10017,50017,40017,40017,90017,30018,70018,100000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
7
7
7
7
7
7
7
7
7
7
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
8
29
29
29
29
29
29
29
29
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
30
31
31
31
31
31
31
31
31
31
31
31
31
31
31
31
31
31
31
31
31
31313131313131313131313131313131313131313030303030303030303030303030303030303030292929292929292988888888888888888888888888888888888888888887777777777000000000000
   Retained Earnings Total Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
44,172
45,340
0
0
0
0
44,700
47,028
50,462
54,275
58,042
63,495
67,547
72,099
73,686
74,649
76,197
77,826
65,313
67,118
68,638
69,995
71,507
73,810
75,343
75,278
77,574
83,392
-99,810
-97,027
-106,339
-102,867
-100,201
-96,817
-93,357
-86,880
-79,165
-69,587
-61,375
-52,143
-49,304
-42,701
-36,112
-33,620
-31,242
-28,870
-25,184
-21,173
-16,849
0
0
0
0
0
0
0
0000000-16,849-21,173-25,184-28,870-31,242-33,620-36,112-42,701-49,304-52,143-61,375-69,587-79,165-86,880-93,357-96,817-100,201-102,867-106,339-97,027-99,81083,39277,57475,27875,34373,81071,50769,99568,63867,11865,31377,82676,19774,64973,68672,09967,54763,49558,04254,27550,46247,02844,700000045,34044,172000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
-500
-600
-700
-700
-800
-900
-1,000
-1,100
-1,200
-1,392
-1,666
-1,936
-14
12
5
17
-3,226
-24
12
25
35
32
-374
-375
-421
-392
-483
-290
38
-238
-279
-238
-132
313
448
472
-10,940
391
674
907
932
765
813
694
-6
-97
253
571
769
953
766
894
1,108
1,333
1,294
797
907
1,117
848
1,267
1,124
889
505
746
302
-103
359
-231
-773
-1,827
-1,542
-2,570
-2,995
-2,121
-2,117
-2,315
-2,626
-2,508
-2,127
-1,528
-1,635
-2,049
-2,333
-2,053
-2,916
-2,551
-2,296
-2,442
-2,209
-3,333
-2,872
-2,623
-2,399
-2,343
-2,269
-2,377
-2,375
-2,324
-2,423
-2,608
0
0
0
0
0
0
0
0
0
0
0000000000-2,608-2,423-2,324-2,375-2,377-2,269-2,343-2,399-2,623-2,872-3,333-2,209-2,442-2,296-2,551-2,916-2,053-2,333-2,049-1,635-1,528-2,127-2,508-2,626-2,315-2,117-2,121-2,995-2,570-1,542-1,827-773-231359-1033027465058891,1241,2678481,1179077971,2941,3331,108894766953769571253-97-6694813765932907674391-10,940472448313-132-238-279-23838-290-483-392-421-375-37432352512-24-3,22617512-14-1,936-1,666-1,392-1,200-1,100-1,000-900-800-700-700-600-500000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30,059
30,630
0
0
0
0
39,514
40,832
41,049
41,298
42,192
43,614
43,859
44,127
44,864
45,370
45,745
43,335
44,103
43,519
45,645
46,345
46,725
48,787
49,620
50,121
51,025
52,216
155,614
156,384
157,312
158,247
158,691
160,524
162,154
165,631
167,808
170,052
171,785
172,642
172,844
173,112
173,942
174,227
174,561
175,162
175,453
176,057
176,646
0
0
0
0
0
0
0
0000000176,646176,057175,453175,162174,561174,227173,942173,112172,844172,642171,785170,052167,808165,631162,154160,524158,691158,247157,312156,384155,61452,21651,02550,12149,62048,78746,72546,34545,64543,51944,10343,33545,74545,37044,86444,12743,85943,61442,19241,29841,04940,83239,514000030,63030,059000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000-78,267-75,949-72,303-56,828-50,149-44,937-44,937-44,937-43,727-41,144-40,228-38,151-33,726-32,320-30,257-30,120-29,004-27,195-26,684-38,225-36,953-35,057-35,036-34,547-32,830-32,830-32,538-32,376-32,229-32,031-30,735-30,378-30,058-29,716-29,716-29,716-28,810-28,810-28,810-28,810-28,604-26,147-25,331-25,214-23,436-23,265-22,989-22,919-22,845-22,845-22,845-22,682-22,382-22,377-22,371-22,365-22,298-19,614-18,806-18,717-12,165-12,105-12,040-11,976-11,924-11,698-10,752-10,688-10,688-8,017-8,017-5,050-4,756-4,703-3,684-3,067-1,869-1,645-1,596-1,596-1,596-1,522-1,503-1,503-1,503-1,503-1,503-1,503-1,503-1,491-1,491-1,491000000000000
   Other Stockholders Equity 
0
0
0
17,300
17,500
17,500
17,500
15,700
16,500
15,500
15,500
15,400
15,355
15,395
15,449
15,462
15,525
15,551
15,586
0
15,797
16,054
16,277
16,528
16,575
16,994
17,015
-15,798,863
-16,973,983
15,516
14,462
14,590
14,687
11,880
12,001
9,358
9,640
10,099
9,672
0
10,350
10,707
10,973
11,343
5,558
5,897
6,194
4,919
5,021
5,234
5,258
5,489
5,375
5,429
5,738
6,125
6,473
7,070
7,162
7,644
8,200
8,949
9,733
10,910
12,022
12,239
12,488
13,382
13,898
14,143
14,411
14,806
14,992
15,010
11,304
11,874
11,143
13,107
13,515
13,895
14,240
14,584
15,064
14,072
13,991
128,930
129,189
128,308
128,127
128,138
127,762
128,219
127,480
127,580
128,908
128,058
127,705
127,907
128,175
123,793
117,399
102,258
99,213
97,186
95,807
94,568
94,323
79,454
63,950
63,893
55,447
48,317
43,653
43,65348,31755,44763,89363,95079,45494,32394,56895,80797,18699,213102,258117,399123,793128,175127,907127,705128,058128,908127,580127,480128,219127,762128,138128,127128,308129,189128,93013,99114,07215,06414,58414,24013,89513,51513,10711,14311,87411,30415,01014,99214,80614,41114,14313,89813,38212,48812,23912,02210,9109,7338,9498,2007,6447,1627,0706,4736,1255,7385,4295,3755,4895,2585,2345,0214,9196,1945,8975,55811,34310,97310,70710,35009,67210,0999,6409,35812,00111,88014,68714,59014,46215,516-16,973,983-15,798,86317,01516,99416,57516,52816,27716,05415,797015,58615,55115,52515,46215,44915,39515,35515,40015,50015,50016,50015,70017,50017,50017,50017,300000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue143,060
Cost of Revenue-56,933
Gross Profit86,12786,127
 
Operating Income (+$)
Gross Profit86,127
Operating Expense-50,933
Operating Income35,19435,194
 
Operating Expense (+$)
Research Development0
Selling General Administrative44,911
Selling And Marketing Expenses0
Operating Expense50,93344,911
 
Net Interest Income (+$)
Interest Income125
Interest Expense-2,595
Other Finance Cost-0
Net Interest Income-2,470
 
Pretax Income (+$)
Operating Income35,194
Net Interest Income-2,470
Other Non-Operating Income Expenses0
Income Before Tax (EBT)32,69037,698
EBIT - interestExpense = 32,690
32,690
27,378
Interest Expense2,595
Earnings Before Interest and Taxes (EBIT)35,28535,285
Earnings Before Interest and Taxes (EBITDA)41,307
 
After tax Income (+$)
Income Before Tax32,690
Tax Provision-7,907
Net Income From Continuing Ops24,78324,783
Net Income24,783
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses107,866
Total Other Income/Expenses Net-2,5042,470
 

Technical Analysis of National Research Corp
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of National Research Corp. The general trend of National Research Corp is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine National Research Corp's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. National Research Corp Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of National Research Corp.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 17.29 < 17.55 < 18.05.

The bearish price targets are: 15.73 > 14.20 > 13.38.

Know someone who trades $NRC? Share this with them.👇

National Research Corp Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of National Research Corp. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

National Research Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of National Research Corp. The current macd is 0.71539317.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the National Research Corp price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for National Research Corp. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the National Research Corp price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
National Research Corp Daily Moving Average Convergence/Divergence (MACD) ChartNational Research Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of National Research Corp. The current adx is 33.35.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell National Research Corp shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
National Research Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of National Research Corp. The current sar is 15.82.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
National Research Corp Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of National Research Corp. The current rsi is 60.60. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
National Research Corp Daily Relative Strength Index (RSI) ChartNational Research Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of National Research Corp. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the National Research Corp price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
National Research Corp Daily Stochastic Oscillator ChartNational Research Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of National Research Corp. The current cci is 23.32.

National Research Corp Daily Commodity Channel Index (CCI) ChartNational Research Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of National Research Corp. The current cmo is 13.27.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
National Research Corp Daily Chande Momentum Oscillator (CMO) ChartNational Research Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of National Research Corp. The current willr is -50.16722408.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that National Research Corp is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
National Research Corp Daily Williams %R ChartNational Research Corp Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of National Research Corp.

National Research Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of National Research Corp. The current atr is 0.66815019.

National Research Corp Daily Average True Range (ATR) ChartNational Research Corp Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of National Research Corp. The current obv is 290,058.

National Research Corp Daily On-Balance Volume (OBV) ChartNational Research Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of National Research Corp. The current mfi is 60.73.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
National Research Corp Daily Money Flow Index (MFI) ChartNational Research Corp Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for National Research Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-26BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-28RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-03-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-14MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-03-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-28STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-31STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-02STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-04RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-04-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-04-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-08BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-05-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-05WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-06-06ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-13MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-20MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-24CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.

6.3. Candlestick Patterns

National Research Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of National Research Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.599
Ma 20Greater thanMa 5016.209
Ma 50Greater thanMa 10014.204
Ma 100Greater thanMa 20014.210
OpenGreater thanClose16.573
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of National Research Corp with someone you think should read this too:
  • Are you bullish or bearish on National Research Corp? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about National Research Corp? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about National Research Corp

I send you an email if I find something interesting about National Research Corp.


Comments

How you think about this?

Leave a comment

Stay informed about National Research Corp.

Receive notifications about National Research Corp in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.